Christopher Lepsy
Impact in
- Pharmacology top 10%
- Spectroscopy top 10%
- Mass Spectrometry Techniques and Applications
- Analytical Chemistry and Chromatography
Papers in
-
- Protein purification and stability 3
- Oncology 7
- CAR-T cell therapy research 4
- Co-authors
- Chengjie Ji (3 shared papers)Nalini Sadagopan (2 shared papers)Wenlin Li (2 shared papers)Yizhong Zhang (1 shared paper)Vitaly Ablamunits (1 shared paper)Rouba Kozak (1 shared paper)Scott Fountain (1 shared paper)Ayman El‐Kattan (1 shared paper)
- Journals
- The AAPS Journal (5 papers)Journal of Pharmaceutical Sciences (2 papers)Analytical Chemistry (2 papers)Journal of Chromatography B (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- United StatesPolandItaly
In The Last Decade
Christopher Lepsy
18 papers receiving 407 citations
Peers
Comparison fields: 5 of 80
- Pharmacology 45
- Spectroscopy 76
- Immunology 89
- Molecular Biology 166
- Computational Theory and Mathematics 38
Countries citing papers authored by Christopher Lepsy
This map shows the geographic impact of Christopher Lepsy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Lepsy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Lepsy more than expected).
Fields of papers citing papers by Christopher Lepsy
This network shows the impact of papers produced by Christopher Lepsy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Lepsy. The network helps show where Christopher Lepsy may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Lepsy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 77 | |
| 2 | 2021 | 60 | |
| 3 | 2008 | 56 | |
| 4 | 2009 | 50 | |
| 5 | 2004 | 30 | |
| 6 | 2022 | 25 | |
| 7 | 2019 | 21 | |
| 8 | 2009 | 20 | |
| 9 | 2003 | 20 | |
| 10 | 2009 | 16 | |
| 11 | 2016 | 12 | |
| 12 | 2022 | 9 | |
| 13 | 2020 | 6 | |
| 14 | 2012 | 4 | |
| 15 | 2019 | 4 | |
| 16 | 2023 | 3 | |
| 17 | 2025 | 3 | |
| 18 | 2020 | 1 |
About Christopher Lepsy
Christopher Lepsy is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Epidemiology, having authored 18 papers that have together received 417 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), Biosimilars and Bioanalytical Methods (5 papers), CAR-T cell therapy research (4 papers), Inflammatory Bowel Disease (3 papers), Protein purification and stability (3 papers), Computational Drug Discovery Methods (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Pharmacology (45 citations), Spectroscopy (76 citations), Immunology (89 citations), Molecular Biology (166 citations) and Computational Theory and Mathematics (38 citations). Christopher Lepsy has collaborated with scholars based in United States, Poland and Italy. Frequent co-authors include Chengjie Ji, Nalini Sadagopan, Wenlin Li, Yizhong Zhang, Vitaly Ablamunits, Rouba Kozak, Scott Fountain, Ayman El‐Kattan, Eric Gifford and Charles J. Stankovic. Their work appears in journals such as The AAPS Journal, Journal of Pharmaceutical Sciences, Analytical Chemistry, Journal of Chromatography B and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.